1) Clear suitability guidance
We assess whether mistletoe therapy is appropriate in your situation, including timing alongside chemotherapy, radiotherapy, immunotherapy, or recovery phases.
Mistletoe Therapy
A clinician-led suitability assessment for mistletoe therapy (Viscum album) to support your cancer journey alongside conventional oncology care. We review safety, timing, medications/supplements, and your goals—then advise the safest next step.
Prefer to explore first? Visit Mistletoe therapy (overview), review Evidence & safety for mistletoe therapy, see Mistletoe therapy cost, and explore Mistletoe brands (Iscador, Abnoba Viscum, Helixor).
We assess whether mistletoe therapy is appropriate in your situation, including timing alongside chemotherapy, radiotherapy, immunotherapy, or recovery phases.
We review your medications and supplements to reduce avoidable risk and ensure your plan is coordinated with your wider care.
If suitable, you receive a clear plan for delivery, monitoring, and follow-up—designed to work alongside your oncology care.
This appointment is designed for people who want a clinician-led view on whether mistletoe therapy can be integrated safely as supportive care. You may be:
Important: Mistletoe therapy is offered as supportive care within an integrative approach. It does not replace conventional oncology treatment.
We review your diagnosis, current treatment plan, and any relevant medical history to understand your risk profile and goals.
We clarify what matters most to you—often energy, sleep, appetite, comfort, emotional wellbeing, and a sense of clarity and control.
We review your medication and supplement list, and discuss treatment timing to reduce avoidable risk and avoid conflicting interventions.
You receive clear guidance on suitability and a recommended pathway. If mistletoe therapy is appropriate, we explain how it would be delivered and monitored.
To keep the consultation efficient and clinically useful, please bring or send (if available):
If you’re not sure what’s relevant, submit what you have. We’ll tell you what would be helpful next.
Safety is central. We aim to integrate supportive therapies in a way that is compatible with your oncology care and your individual risk profile.
For the full safety page, read: Evidence & safety for mistletoe therapy.
Where appropriate, we can align recommendations with your existing care plan and help you communicate supportive-care decisions clearly. The goal is transparency and risk reduction—not conflicting advice.
If you want context first, start at: Mistletoe therapy (overview).
Want to understand brands first? Visit: Mistletoe brands (Iscador, Abnoba Viscum, Helixor).
Consultation pricing and ongoing costs depend on what support you need and how your plan is monitored. For transparent pricing details, see: Mistletoe therapy cost.
If you prefer to understand the therapy context before booking, go to: Mistletoe therapy (overview).
No referral is required. If you have clinic letters or a treatment summary, they help us work more efficiently.
Where appropriate, we can help you communicate supportive-care decisions clearly and safely, aligned with your current treatment plan.
That’s exactly what this consultation is for. If you’d like to read first, start with the mistletoe therapy overview and the evidence & safety page.
No. It is offered as supportive care within an integrative approach and is not intended to replace conventional oncology treatment.
If suitable, you’ll receive a clear next-step plan and monitoring guidance. If not suitable (or not the right time), we’ll explain why and discuss safer options.
Submit the form below and our clinic team will contact you about appointment options. If you feel suddenly unwell during cancer treatment, seek urgent assessment.
Prefer to read first? Review: Evidence & safety for mistletoe therapy and Mistletoe therapy cost.
Disclaimer: Mistletoe therapy is offered as supportive care within an integrative cancer care model. It is not intended to replace conventional oncology treatment. Always seek clinician guidance before starting or combining therapies.



